Skip to content

Drug interactions

Istradefylline + Sorafenib

Severity: Minor

Istradefylline and Sorafenib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Istradefylline at 40 mg/day weakly inhibits CYP3A4 and raised exposure of CYP3A4 substrates. Sorafenib exposure may rise modestly, though sorafenib is cleared by CYP3A4 and UGT1A9 and the effect is likely small.

What this interaction means in plain words

Istradefylline and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Istradefylline belongs to Central Nervous System; Sorafenib belongs to Oncology.

Evidence level: Low

Why it happens

Istradefylline inhibits CYP3A4 at higher doses, reducing sorafenib oxidative metabolism.

What to do

Monitor for sorafenib adverse effects such as hand-foot skin reaction, hypertension and diarrhea. Keep istradefylline at 20 mg/day where possible.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Istradefylline and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Istradefylline with Sorafenib?

MediHelp rates the interaction as minor. Istradefylline and Sorafenib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Istradefylline at 40 mg/day weakly inhibits CYP3A4 and raised exposure of CYP3A4 substrates. Sorafenib exposure may rise modestly, though sorafenib is cleared by CYP3A4 and UGT1A9 and the effect is likely small.

How serious is the interaction between Istradefylline and Sorafenib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for sorafenib adverse effects such as hand-foot skin reaction, hypertension and diarrhea. Keep istradefylline at 20 mg/day where possible.

What other medicines interact with Sorafenib?

MediHelp also lists interactions of Sorafenib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sorafenib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in